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Background: Osteoarthritis is the most common musculoskeletal disease
worldwide. Spinal osteoarthritis (OA) is a frequent cause of back pain and
disability in patients over 60. The frequency of radiographically-evident dorsal and
lumbar OA in Latin America is unknown
Objectives: To determine the prevalence of dorsal and lumbar vertebral OA in a
database-driven random sample of women 50 years of age and older from the
Latin-American Vertebral Osteoporosis Study (LAVOS) in 5 LA countries (México,
Brazil, Argentina, Colombia and Puerto Rico)
Methods: Lumbar and Dorsal X-rays were performed per a standardized
protocol and analyzed independently by two trained radiologists and a general
practitioner using the Lane score to establish diagnosis and degree of vertebral
OA severity. Inter and intra observer agreement was determined to be k>0.6.
Descriptive statistics were used to analyze demographic variables. Prevalence
was determined using means and standard deviations for quantitative variables
and simple frequencies and percentages for qualitative variables. Bivariate
analysis was performed to associate age, BMI and other variables with the
presence of OA, using c2 and the magnitude of association through OR and 95%
CI, carrying out a multivariate analysis to adjust the frequency of OA to other
variables
Results: 405 women, mean age 69.4 (58–80), median weight 64 kg (56.9–73.4)
mean height 151.8 cm (±7.6) were analyzed. 5.65% were underweight, 21%
had normal weight, 41.6% were overweight and 31.5% were obese. Argentina
contributed 19% of the sample, Brazil 14.8%, Colombia 20.1%, México 33.3%
and Puerto Rico 12.8%. OA prevalence per age group was 76.3% (95% CI
68.4–84.2) in those 50–59, 83.8% (95% CI76.6–91.2) in those 60–69, 84.3%
(95% CI 76.7–91.7) in those 70–79 and 94.9% (95% CI 90.4–99.3) in those 80
or older (p=0.003). Prevalence per country was as follows: Brazil 93%, Colombia
90%, México 85%, Puerto Rico 79% and Argentina 74%. Prevalence per BMI
was 80% in normal weight, 82.5% in overweight and 87.5% in obese. 72.6% of
sampled women had dorsal OA (Argentina 48.1%, Brazil 65%, Puerto Rico 73.1%,
México 79.3%, Colombia 90.1%). Obesity was a risk factor for the development
of dorsal OA (OR 2.46) when compared to normal BMI (p=0.01). Lumbar OA was
found in 44.9% of the sampled women (Argentina 68.8%, Brazil 65%, Colombia
and Puerto Rico 42.3% each, México 37%). Adjusting for age, BMI, height loss,
steroid use and physical activity, the OR for presenting OA is 6.45 (p<0.001) in
women over 80 compared to those 50–59
Conclusions: Radiographic OA is highly prevalent in Latin American women
over 50 and associated with progressing age and BMI. Brazil has the highest
prevalence of OA.
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Background: Selective cyclooxigenase (COX)-2 inhibitors were developed to
prevent NSAIDs gastro-intestinal adverse effects. VA692, a new hydroxyetyl
selective COX-2 inhibitor, showed anti-inflammatory, anti-nociceptive and chon-
droprotective properties. Proteomics is being applied for the study of drug mode
of action, toxicity and to identify new drugs targets.
Objectives: The aim of this study was to analyze the anti-inflammatory effect of
VA692, in comparison with celecoxib. By iTRAQ methodology, we quantitatively
analyzed the different expressed profiles in T/C-28a2 cell line treated with the
studied drugs in presence of IL-1β.
Methods: Human T/C-28a2 chondrocytes cell line were generated by Goldring
group. Human articular cartilage was obtained from femoral heads of five OA
patients. Cells were incubated with VA692 and celecoxib (1, 0.5 and 0.2μM) in
presence of Interleukin (IL)-1β (5ng/ml) for 48h. The expression of inflammatory
cytokines and anti-oxidant enzymes was evaluated by quantitative qRT-PCR,
PGE2 release by ELISA, and apoptosis and ROS production by flow cytometry.
T/C-28a2 cell line was also processed to carry out western blot tests and finally
employed for the iTRAQ analysis. Statistical analysis was performed by ANOVA
and Bonferroni multiple comparison tests.
Results: IL-1β-stimulated chondrocytes showed a significant increase (p<0.001)
of COX-2, IL-1β, IL-6, IL-8, superoxide dismutase (SOD)-2 and catalase (CAT)
gene expression, as well as of PGE2 levels. The tested drugs significantly
counteracted the effect of IL-1β, with a better modulation by VA692 1μM in
T/C-28a2 cell line (p<0.01 for COX-2, IL-1β, IL-8, CAT; p<0.001 for IL-6, SOD-2).
Regarding apoptosis and ROS production, the new drug was able to significantly
reduce (p<0.05) their increase induced by IL-1β (p<0.05). Proteomic analysis
led to identification of 797 proteins in T/C28a2 cell line, 123 of which were
significantly modulated by VA692 in presence of IL-1β (p<0.001), and 34 by
IL-1β alone (p<0.05). 22 proteins were commonly modulated in both groups,
thus indicating that 101 proteins were regulated by VA692 in a specific manner.
Among the proteins down-regulated by VA692, some with structural function were
detected, responsible for cytoskeleton riorganization, as well as chaperones (heat
shock proteins) and glycolitic enzymes. Proteins involved in calcium metabolism
and in ribosome biogenesis resulted up-regulated instead, as well as SOD-2 as
confirmed by western blot analysis.
Conclusions: Our data demonstrated the anti-inflammatory effect of VA692,
suggesting also its anti-apoptotic and anti-oxidant role. The proteomic profile
showed that VA692 induced not only an anti-inflammatory effect in chondrocytes
but, interestingly, this compound also seemed to regulate their anabolic response.
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Background: EULAR guidelines for osteoarthritis (OA) endorse high quality care
and support to self-manage with core recommended treatments such as exercise,
weight loss and the provision of written information and education. An EU-funded
project, Joint Implementation of Guidelines for oSteoArthritis in Western Europe
(JIGSAW-E)1, aims to improve the management of OA across five European
countries (UK, Netherlands, Norway, Denmark, Portugal) by implementing an
intervention to enhance the OA consultation.
Coordinated, cross-border Patient and Public Involvement and Engagement
(PPIE), working in active partnership with the project team, is an essential
component of JIGSAW-E.
Objectives: To describe the PPIE in the JIGSAW-E project.
Methods: A two-day international workshop established the JIGSAW-E Patient
Panel to act as the voice of patients and the public in the project and to co-develop
clear information and resources for patients. Panel members meet regularly with
the project teams in each country. The Patient Panel is coordinated and supported
by dedicated PPIE teams in the UK and Netherlands.
Results: The JIGSAW-E Patient Panel consists of Patient Champions and patient
representatives from newly established or existing patient groups in each of
the five countries. The Patient Champions form a core group of seven patient
representatives who work closely with the Patient Panel and the JIGSAW-E team.
PPIE activities have included:
• One Patient Champion sits on the JIGSAW-E project steering committee.
• In the Netherlands, Patient Panel members substantially contributed to the
translation and cultural adaptation of a guidebook for patients with OA. This
process will continue as JIGSAW-E is rolled out in each of the five countries.
• Patient Panel members in the UK have helped refine an OA Quality Indicator
questionnaire2 for use in JIGSAW-E.
A glossary of terms has been developed to support the involvement of Patient
Panel members throughout the project.
Conclusions: Effective and meaningful PPIE is a central component to delivery
and success of raising awareness and implementing the OA management
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recommendations on a national level. The Patient Panel represents a step
forward in international collaboration of PPIE within implementation projects. The
Patient Panel is producing culturally appropriate and relevant information and
resources for patients in five European countries. Future activities may include
the development of patient stories to support increased adoption of JIGSAW-E,
providing the patient perspective during training of health care professionals, and
the digitisation of patient resources into Smartphone or tablet Apps.
References:
[1] https://goo.gl/a4xYUV.
[2] Blackburn et al. Res. Involvement and Engagement (2016) 2:5. doi: 10.1186/
s40900-016-0019-x.
Acknowledgements: JIGSAW-E is funded via the West Midlands AHSN by
EITHealth. Funding from the WM AHSN, the Regional Innovation Fund NHS
England and Shropshire CCG. KD is part funded by a Knowledge Mobilisation
Research Fellowship (KMRF201403002) from the NIHR.
Disclosure of Interest: None declared
DOI: 10.1136/annrheumdis-2017-eular.2711
AB0818 PERSONALIZED ARTICULATING JOINT DISTRACTION FOR
TREATMENT OF TIBIOFEMORAL OSTEOARTHRITIS: CLINICAL
FEASIBILITY
T. Struik 1, R.J. Custers 2, N.J. Besselink 1, J.E. Jaspers 3, A.K. Marijnissen 1,
F.P. Lafeber 1, S.C. Mastbergen 1. 1Rheumatology & Clinical Immunology;
2Orthopedics; 3Medical Technology & Clinical Physics, University Medical Center
Utrecht, Utrecht, Netherlands
Background: Osteoarthritis (OA) patients encounter progressive pain and func-
tional disabilities, including joint stiffness, due to degeneration of the joint tissues.
For knee OA, the most prevalent form, available treatment strategies are limited in
number and focus primarily on minimizing the functional disability, inflammation,
and pain in a conservative manner since still no unambiguously proven effective
disease modifying approaches are available. Progress in the development of joint
sparing procedures however, has demonstrated the regenerative capacity of the
osteoarthritic knee and with that the delay for conventional last resort therapy such
as total knee arthroplasty (TKA). Knee Joint Distraction (KJD) is a joint preserving
procedure that can postpone knee arthroplasty in case of knee osteoarthritis for
over 5 years [1]. Distraction is applied with an external fixator for 6–8 weeks.
Objectives: To reduce the burden on patients during treatment originating from
a restriction in joint flexion during KJD, we evaluated an articulating frame. A
personalized articulating KJD-device was developed, biomechanically tested, and
technical feasibility was evaluated in cadaveric legs. Reproduction of joint specific
motion was demonstrated and articulating KJD was concluded to be technically
feasible. In this study, clinical feasibility was tested in 3 patients.
Methods: Patients received rigid knee joint distraction treatment in general
practice. After 2–4 weeks, the frame was removed in the outpatient clinic and the
joint was flexed in a continuous passive motion (CPM) device until 30° flexion
was reached, or motion became painful. Subsequently, the articulating frame was
attached to the bone pins (figure 1), followed by computerized personalization of
the hinge from a non-invasive motion measurement. After assembling the custom
parts, weight-bearing and non-weight-bearing radiographs were taken at 0, 15,
and 30°flexion for joint space width measurements. Finally, the articulating device
was replaced by the rigid frame and treatment was continued according to clinical
practice.
Results: For none of the three patients, the articulating distractor could be
personalized. In the first patient, 15° flexion was achieved on the CPM, but pin
positions did not allow for positioning of the frame. In the other patients, 8° and
15° flexion was measured, which was too little motion for the custom software
to generate personalized hinge parts. Pain at the pin sites during motion was
reported by all patients.
Conclusions: Despite confirmation of joint-specific articulating distraction on
cadaveric legs, clinical feasibility could not be demonstrated, mainly due to painful
motion of soft tissues along the bone pins.
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Background: Elderly people over 65 year-old have increased year by year in
many countries1. Because their rate was from 19.5% at 2004 to 26.8% at 2015
in Japan and 30.8% at 2015 in our super-aging area, the numbers of total joint
arthroplasties have increased too2. In fact, the numbers of total hip arthroplasty
predicted increasing from six hundred fifty-six thousand cases at 2010 to one
million three hundred seventy-six thousand cases at 2020 in USA3. The rate of
total joint arthroplasty, including primary total hip arthroplasty, may reflect trends
in management and health outcomes of elderly people with osteoarthritis (OA) in
our super-aging area of Japan1,4.
Objectives: The aim of this study was to analyze the trend of primary total hip
arthroplasties for the patients with OA in our institutes in the last twelve years.
Methods: We surveyed the number and rate of orthopaedic surgeries and primary
total hip arthroplasties in our two institutes from 2004 to 2015.
Results: We had 19,862 cases of orthopaedic surgeries, including 3,782 primary
total hip arthroplasties in the last twelve years. They have increased year by year
(r=0.92, p<0.05, Fig. 1). Mean age was 64.5 old-year (62.4–66.8) in last twelve
years, had become older year by year (r=0.78, p<0.05), 62.4 old-year at 2004 vs
66.8 old-year at 2015. Mean rate of female was 87% (85–91) in last twelve years,
had gradually decreased year by year (r= -0.68, p<0.05), 91% at 2004 vs 85% at
2015.
Conclusions: The rate of total joint arthroplasties including primary total hip
arthroplasty increased year by year, and related to total numbers of orthopaedic
surgeries in our super-aging area of Japan. Mean age at receiving primary
total hip arthroplasty was older annually but mean rate of women had gradually
decreased year by year. Although majority of OA hip consist of female which have
secondary dysplastic acetabulum in our country2, it might increase gradually the
patients of man with OA hip in super-aging time in Japan.
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